Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Medical Devices & Biomaterials
Filter     Order     Display # 
Date Item Title
28 Mar 2006 Innocoll Announces Initiation of Phase IIA Clinical Study of Bupivacaine Collagen Sponge
28 Mar 2006 Medtronic Receives FDA Approval for New AneuRx® AAAdvantage™ Abdominal Aortic Aneurysm Stent Graft System
28 Mar 2006 TissueLink Medical Announces Presentation of New Clinical Data Documenting Reduction in Blood Loss with the Company's Bipolar Sealing Technology; Findings Presented at the American Academy of Orthopaedic Surgeons 2006 Annual Meeting
25 Mar 2006 Medtronic Receives FDA Approval For Non-Rechargeable Neurostimulator
25 Mar 2006 BSD Medical Applies for FDA Approval of the BSD-2000 Cancer Treatment System
23 Mar 2006 CeraPedics Initiates P-15™ Putty Trial
23 Mar 2006 BioLok International Receives FDA Clearance for Unique and Clinically Safe Time Release Bone Augmentation Product
22 Mar 2006 Orthovita Enters into License Agreement with Angiotech for VITAGEL(TM) Surgical Hemostat
21 Mar 2006 Data Safety Monitoring Board Recommends Continuation of Medidur™ Phase III Clinical Trial
21 Mar 2006 BioMimetic Therapeutics Initiates Clinical Trials with Novel Bio-active Drug-device Combination Bone Graft in Two Orthopedic Indications; GEM OS1(TM) Clinical Trials Initiated in the United States, Canada and Sweden
20 Mar 2006 Orthovita And Aastrom Biosciences Announce Collaboration Agreement For Orthopedic Products
20 Mar 2006 Q-Med submits DUROLANE regulatory file to the US FDA
17 Mar 2006 Guidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further Understand Patient Safety, Increase Patient Access
17 Mar 2006 Conor Medsystems Licenses Pimecrolimus From Novartis for Use in Next-Generation Reservoir-Based Drug-Eluting Stents
16 Mar 2006 Guidant Completes Enrollment in Randomized U.S. Portion of Drug Eluting Stent Pivotal Trial
15 Mar 2006 JAMA Article Says TAXUS® Stents Superior to Brachytherapy in the Treatment of In-Stent Restenosis
15 Mar 2006 Medtronic’s Endeavor™ Stent Continues to Show Consistent Clinical Efficacy and Strong Safety Profile
15 Mar 2006 ARRIVE II registry demonstrates low 2.5 percent TAXUS-related re-intervention rate in complex lesions
14 Mar 2006 NMT Medical's MIST Study Indicates That Closing a PFO Has an Effect on Migraine.
13 Mar 2006 New spacer from Artimplant receives CE-mark
13 Mar 2006 Vasogen Announces Results from Phase III SIMPADICO Trial in Peripheral Arterial Disease
11 Mar 2006 MIV Therapeutics Subsidiary, SagaX Inc., Accelerates Development of Surgical Stroke Prevention Device Towards Commercialization
10 Mar 2006 OccuLogix Reports Positive MIRA-1 Analysis Results
09 Mar 2006 Guidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting Coronary Stent; Innovative Technology Could Represent New Frontier in the Treatment of Heart Disease
09 Mar 2006 Angiotech partner submits final module for TAXUS® Liberte™ coronary stent system application
09 Mar 2006 X-Cell Medical Initiates Enrollment for ETHOS II Clinical Trial of Estradiol Eluting Stent
08 Mar 2006 Micrus Endovascular Receives Approval to Sell Neurovascular Stent in Europe; First Approved Product From Micrus and BIOTRONIK AG Agreement
07 Mar 2006 KeraCure(TM) Initiates Multi-Center Pivotal Study in Diabetic Foot Ulcers
07 Mar 2006 Kensey Nash Announces Low 3.2% MACE Rate Achieved Using New TriActiv FX(R) Embolic Protection System
07 Mar 2006 SurModics Gains Access to Biodegradable Polymer Technology for Site Specific Drug Delivery from InnoCore
03 Mar 2006 Inamed's Phase 3 Study Results for Juvederm(TM) to Be Presented at the 64th Annual Meeting of the American Academy of Dermatology
03 Mar 2006 First Patient Enrolled in St. Jude Medical's Migraine Headache Study; Clinical Trial to Explore Link between Common Heart Defect and Migraine Headaches
02 Mar 2006 Healing Stent Nine Month Mace Rate Similar to Drug Eluting Stents
02 Mar 2006 Amedica Receives FDA Clearance for Its Arx Ceramic Spinal Implant
01 Mar 2006 Delcath Systems Announces Initial Patient Treatment In Phase III Clinical Trial
27 Feb 2006 BioSante Pharmaceuticals Signs Option and License for its CaP Technology for Use in Aesthetic Medicine
24 Feb 2006 DUSA pharmaceuticals reports statistically significant results from phase II clinical trial for PDT of photodamaged skin
22 Feb 2006 AngioJet(R) Therapy Shown Safe and Effective as Part of Rescue Percutaneous Coronary Interventions
20 Feb 2006 Sorin Group: Launch of Second Generation Drug Eluting Stent, Janus Flex With Best in Class Deliverability
18 Feb 2006 ev3 Receives FDA Clearance for SpideRX(TM) Embolic Protection Device for Carotid Artery Stenting
17 Feb 2006 Conor Medsystems Receives CE Mark for CoStar(TM) Drug-Eluting Stent
17 Feb 2006 Anika Therapeutics Receives CE Mark for its REDEFYNE(TM) Cosmetic Tissue Augmentation Product
16 Feb 2006 Kensey Nash Receives CE Mark Approval for New TriActiv(R) ProGuard(TM) Embolic Protection System
15 Feb 2006 Pegasus Biologics, Inc. Introduces the OrthADAPT(TM) Bioimplant -- A Revolutionary New Biologic Scaffold for Orthopedic Soft Tissue Reinforcement
13 Feb 2006 Head-to-Head Study Shows EUFLEXXA(TM) Has Greater Tolerability Compared to Synvisc(R) for Osteoarthritis Knee Pain
09 Feb 2006 Minnesota Company Announces Approval to Begin U.S. Migraine Study
08 Feb 2006 Centers for Disease Control and Prevention (CDC) and Ceragenix Enter into a Cooperative Research and Development Agreement (CRADA)
08 Feb 2006 Metvix PDT in acne: New study published in British Journal of Dermatology
07 Feb 2006 Starpharma: Market Update
07 Feb 2006 NUCRYST Pharmaceuticals announces European approval for Acticoat™ Moisture Control
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>
Results 201 - 250 of 271

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics